# A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)

> **NCT03324880** · PHASE4 · COMPLETED · sponsor: **Shire** · enrollment: 93 (actual)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **BIOLOGICAL:** rhPTH (1-84)
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03324880
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2022-05-19
- **Final completion:** 2022-05-19
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03324880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03324880, "A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03324880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*